Overview Mass Balance Study of MT-1303 Status: Completed Trial end date: 2014-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to investigate the absorption, metabolism and excretion of MT-1303 in healthy subjects. Phase: Phase 1 Details Lead Sponsor: Mitsubishi Tanabe Pharma Corporation